Category Archives: DTC Advertising

More Letters from the Hill – Looking at DTC

The flurry of paper trailing down Capitol Hill to various folks working in and regulating the pharmaceutical industry continues.  Recently members of both the House and the Senate have sent letters to manufacturers of treatments that have lately been in … Continue reading

Posted in DTC Advertising | Comments Off

If a Tree Falls in the Forest….

If a tree falls in the forest, and almost no one notices, did the tree almost not fall?  Pharmaceutical Executive noticed, but I didn’t notice anyone else notice.  I’m talking about the long-proposed user fee program for the FDA’s Division … Continue reading

Posted in DTC Advertising, FDA Policy, Marketing | 2 Comments

New DTC Oversight Powers Given FDA – Show Me the Money!

I was fascinated to read the RPM Report analysis of the new system that will emerge when the new FDA bill is signed into law.  A new user fee program for review of DTC ads will exist that allows the … Continue reading

Posted in DTC Advertising, FDA Policy, Legislation, Marketing | 1 Comment

What a Ban on DTC Means for Public Relations

There have been several proposals before Congress which, in one way or another, have the potential to impact the amount of direct-to-consumer advertising (DTC) allowed.   Some would give the FDA authority to restrict such advertising.  Others have called for it … Continue reading

Posted in DTC Advertising, Proposed Legislation | Comments Off

The News on the News

Since there was so little activity this week given the holiday and the Ford funeral, there is no Weekly Roundup today. But I took the opportunity to do something I’ve wanted to do for a long time.  Longtime readers will … Continue reading

Posted in DTC Advertising | 1 Comment